A look at clinical applications and developments of photodynamic therapy

Oncology Reviews

Volumn 2, Issue 4, 2008, Pages 235-249

  Serra, Arménio ^a   Pineiro, Marta ^a   Pereira, Nelson ^a   Gonsalves, António Rocha ^a   Laranjo, Mafalda ^b   Abrantes, Margarida ^b   Botelho, Filomena ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Cancer; Clinical; Photodynamic therapy; Photosensitizers; Pre clinical

Indexed keywords

EID: 66749175735     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.1007/s12156-008-0081-1     Document Type: Review

References (106)

1. National Cancer Institute, U.S. National Institute of Health. http://www.cancer.gov and http://progressreport.cancer.gov/ accessed on 22 July 2008
2. Brown SB, Brown EA, Walker I (2004) The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 5:497-508 (Pubitemid 39069400)
3. Ackoyd R, Kelty C, Brown N, Reed M (2001) The history of photodetection and photodynamic therapy. Photochem Photobiol 74:656-669
4. Qiang Y, Zhang X, Li J, Huang Z (2006) Photodynamic therapy for malignant and non-malignant diseases: clinical investigation and application. Chin Med J 119:845-857 (Pubitemid 43796815)
5. Lighdale CJ, Heier SK, Marcon NE (1995) Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 42:507-512
6. Overholt BF, Lightdale CJ, Wang KK (2005) Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62:488-498 (Pubitemid 41383764)
7. Hur C, Nishioka NS, Gazelle GS (2003) Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Dig Dis Sci 48:1273-1283 (Pubitemid 36793904)
8. Triesscheijn M, Baas P, Schellens JHM, Stewart F (2006) Photodynamic therapy in oncology. The Oncologist 11:1034-1044 (Pubitemid 44564813)
9. Moghissi K, Dixon K, Thorpe AC et al (2000) The role of photodynamic therapy (PDT) in inoperable oesophageal cancer. Eur J Cardio-thoracic Surg 17:95-100 (Pubitemid 30145579)
10. Zhang NZ, Zhu Y, Pan W et al (2007) Photodynamic therapy combined with local chemotherapy for the treatment of advanced esophagocardiac carcinoma. Photodiagn and Photodyn Ther 4:60-64 (Pubitemid 46274567)
11. Overholt BF, Panjehpour M (1997) Photodynamic therapy for Barrett's esophagus. Gastrointest Endosc Clin N Am 7:207-220 (Pubitemid 27174047)
12. Wolfsen HC (2002) Photodynamic therapy for mucosal esophageal adenocarcinoma and dysplastic Barrett's esophagus. Dig Dis 20:5-17
13. Craig C, Gray J, Macpherson M et al (2007) Porfimer sodium photodynamic therapy in the treatment of early oesophageal carcinoma. Photodiagn and Photodyn Ther 4:244-248 (Pubitemid 350152067)
14. Filonenko EV, Sokolov VV, Chissov VI et al (2008) Photodynamic therapy of early esophageal cancer. Photodiagn Photodyn Ther. Article in press
15. Mitton D, Akroid R (2008) A brief overview of photodynamic therapy in Europe. Photodiag Photodyn Ther 5:103-111
16. Ortner M (2001) Photodynamic therapy for cholangiocarcinoma. J Hepatobiliary Pancreat Surg 8:137-139 (Pubitemid 33690527)
17. Wiedmann MW, Caca K (2004) General principles of photodynamic therapy (PDT) and gastrointestinal applications. Curr Pharmaceut Biotechnol 5:397-408 (Pubitemid 39157795)
18. Fan BG, Andren-Sandberg A (2007) Photodynamic therapy for pancreatic cancer. Pancreas 34:385-389 (Pubitemid 46725777)
19. Spinelli P, Calarco G, Mancini A, Ni XG (2006) Operative colonoscopy in cancer patients. Minim Inv Ther 15:339-347 (Pubitemid 46029436)
20. Nakamura T, Fukui H, Ishii Y et al (2003) Photodynamic therapy with polypectomy for rectal cancer. Gastrointest Endosc 57:266-269 (Pubitemid 36236777)
21. Chen M, Pennathur A, Luketich JD (2006) Role of photodynamic therapy in unresectable esophageal and lung cancer. Lasers Surg Med 38:396-402
22. Moghissi K, Dixon BA (2008) Update on the current indications, practice and results of photodynamic therapy (PDT) in early central lung cancer (ECLC). Photodiag Photodyn Ther 5:10-18
23. Furuse K, Fukuoka M, Kato H et al (1993) A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer J Clin Oncol 11:1852-1857 (Pubitemid 23304607)
24. Moghissi K, Dixon K, Thorpe JA et al (2007) Photodynamic therapy (PDT) in early central lung cancer: a treatment option for patients ineligible for surgical resection. Thorax 62:374-375
25. Maziak DE, Markman BR, MacKay JA, Evans WK (2004) Photodynamic therapy in nonsmall cell lung.cancer: a systematic review. Ann Thorac Surg 77:1484-1491 (Pubitemid 38452417)
26. Usuda J, Kato H, Okunaka T et al (2006) Photodynamic therapy (PDT) for lung cancers. J Thor Oncol 1:489-493 (Pubitemid 47181428)
27. Manyak MJ, Ogan K (2003) Photodynamic therapy for refractory superficial bladder cancer: long-term clinical outcomes of single treatment using intravesical diffusion medium. J Endourol 17:633-639 (Pubitemid 37362913)
28. Fasanella KE, McGrath K (2008) Successful palliative treatment of duodenal metastatic melanoma with photodynamic therapy. Gastrointest Endosc. Article in press
29. Krammer B, Plaetzer K (2008) ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci 7:283-289 (Pubitemid 351501306)
30. Morton CA, Brown SB, Collins S et al (2002) Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 146:552-567 (Pubitemid 34437765)
31. Soler AM, Warloe T, Berner A, Giercksky KE (2001) A followup study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 145:467-471 (Pubitemid 32953705)
32. Allison RR, Sibata CH, Downie GH, Cuenca RE (2006) A clinical review of PDT for cutaneous malignancies. Photodiagn and Photodyn Ther 3:214-226 (Pubitemid 46053864)
33. Marmur ES, Schmults CD, Goldberg DJ (2004) A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 30:264-271 (Pubitemid 38313984)
34. Wang X, Wang HW, Guo MX, Xub SZ (2008) Treatment of skin cancer and pre-cancer using topical ALA PDT - A single hospital experience. Photodiagn and Photodyn Ther 5:127-133
35. MacCormak MA (2008) Photodynamic therapy in dermatology: an update on applications and outcomes. Semin Cutan Med Surg 27:52-62
36. Szeimies RM, Morton CA, Sidoroff A, Braathen LR (2005) Photodynamic therapy for non-melanoma skin cancer. Acta Derm Venereol 85:483-490 (Pubitemid 43087284)
37. Dougherty TJ, Gomer CJ, Henderson BW et al (1998) Photodynamic therapy. J Nat Cancer Inst 90:889-905 (Pubitemid 28304157)
38. Hopper C (2000) Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol 1:212-219
39. Berger AP, Steiner H, Stenzl A et al (2003) Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study. Urology 61:338-341 (Pubitemid 36206528)
40. Szygula M, Pietrusa A, Adamek M et al (2004) Combined treatment of urinary bladder cancer with the use of photodynamic therapy (PDT) and subsequent BCG-therapy: a pilot study. Photodiag Photodyn Ther 1:241-246 (Pubitemid 40614470)
41. Skyrme RJ, French J, Datta SB et al (2005) A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma. Br J Urol Int 95:1206-1210 (Pubitemid 40799431)
42. Stummer W, Beck T, Beyer W et al (2008) Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report. J Neurooncol 87:103-109
43. Stylli SS, Haye AH (2006) Photodynamic therapy of cerebral glioma - a review, part II - clinical studies. J Clin Neurosci 13:709-717 (Pubitemid 44354170)
44. Usuda J, Tsutsui H, Honda H et al (2007) Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofluorescence bronchoscopy. Lung Cancer 58:317-323 (Pubitemid 350051502)
45. Usuda J, Kato H, Okunaka T et al (2006) Photodynamic Therapy using Laserphyrin for centrally located early stage lung cancer. J Clin Oncol 24:7229-7234
46. Waterfield EM, Renke ME, Smits CB et al (2008) Wavelengthdependent effects of benzoporphyrin derivative monoacid ring Ain vivo and in vitro. Photochem Photobiol 60:383-387
47. Lou PJ, Jones L, Hopper C (2003) Clinical outcomes of photodynamic therapy for head and neck cancer. Technol Cancer Res Treat 2:311-317 (Pubitemid 37022347)
48. Wenig BL, D'Cruz A, Iqbal A, Bryce RP (2000) Foscan-mediated photodynamic therapy in the palliative treatment of advanced head and neck cancer. Proc Am Soc Clin Oncol 10: abstr 165
49. Copper MP, Tan IB, Oppelaar H et al (2003) Meta-tetra(hydroxyphenyl) chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 129:709-711 (Pubitemid 36858954)
50. Hopper C, Kübler A, Lewis H et al (2004) mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int J Cancer 111:138-146 (Pubitemid 38859295)
51. Kübler AC, de Carpentier J, Hopper C et al (2001) Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy. Int J Oral Maxillofac Surg 30:504-509
52. Lou PJ, Jager HR, Jones L et al (2004) Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer 91:441-446 (Pubitemid 39093561)
53. Avetisov SE, Budzinskaia MV, Likhvantseva VG et al (2005) The first results of phase IIA of clinical studies of photodynamic therapy for subretinal neovascular membranes with photosense. Vestn Oftalmol 121:6-9
54. Chou TM, Woodburn KW, Cheong WF et al (2002) Photodynamic therapy: applications in atheroscierotic vascular disease with motexafin lutenium. Catheter Cardiovasc Interv 57:387-394 (Pubitemid 35266279)
55. Selman SH, Albrecht D, Keck RW et al (2001) Studies of tin ethyl etiopurpurin photodynamic therapy of the canice prostate. J Urol 165:1795-1801 (Pubitemid 32410311)
56. Sibonia G, Amit-Patitoa I, Weizmana M et al (2003) Specificity of photosensitizer accumulation in undifferentiated versus differentiated colon carcinoma cells. Cancer Lett 196:57-64
57. Mang TS (2004) Lasers and light sources for PDT: past, present and future. Photodiag. Photodyn Ther 1:43-48 (Pubitemid 40311382)
58. Serra AC, Pineiro M, Rocha Gonsalves AMDA et al (2008) Halogen atom effect on photophysical and photodynamic characteristics of derivatives of 5, 10, 15, 20-tetrakis(3-Hydroxyphenyl) porphyrin. J Photochem Photobiol B Biol 92:61-67
59. Laville I, Pigaglio S, Blais JC et al (2006) Photodynamic efficiency of diethylene glycol-linked glycoconjugated porphyrins in human retinoblastoma cells. J Med Chem 49:2558-2567
60. Laville I, Figueiredo T, Loock B et al (2003) Synthesis, cellular internalization and photodynamic activity of glucoconjugated derivatives of tri and tetra(meta-hydroxyphenyl)chlorins. Bioorg Med Chem 11:1643-1652 (Pubitemid 36349145)
61. Bourré L, Simonneaux G, Ferrand Y et al (2003) Synthesis, and in vitro and in vivo evaluation of a diphenylchlorin sensitizer for photodynamic therapy. J Photochem Photobiol B Biol 69:179-192 (Pubitemid 36503387)
62. Hilmey DG, Abe M, Nelen MI et al (2002) Water-soluble, core modified porphyrins as novel longer-absorbing sensitizers for photodynamic therapy.2. Effects of core heteroatoms and mesosubstituents on biological activity. J Med Chem 45:449-461 (Pubitemid 34073462)
63. Johnstone RAW, Nunes MLPG, Pereira MM et al (1996) Improved syntheses of 5, 10, 15, 20-tetrakisaryl- and tetrakisalkylporphyrins. Heterocycles 43:1423-1437
64. Jori G, Reddi E, (1993) The role of lipoproteins in the delivery of tumor-targeting photosensitizers. Int J Biochem 25:1369-1375 (Pubitemid 23285684)
65. Konan YN, Gurny R, Allemann E (2002) State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B 66:89-106 (Pubitemid 34240266)
66. Vemuri S, Rhodes CT (1995) Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharm Acta Helv 70:95-111
67. Derycke ASL, Witte PAM (2004) Liposomes for photodynamic therapy. Adv Drug Deliv Rev 56:17-30 (Pubitemid 38045422)
68. Jiang L, Lilge L, Grenier J et al (1998) Photodynamic therapy of U87 human glioma in nude rat using liposome-delivered photofrin. Laser Surg Med 22:74-80 (Pubitemid 28080138)
69. Igarashi A, Konno H, Tanaka T, Nakamura S, Sadzuka Y, Hirano T (2003) Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer. Toxicol Lett 145:133-141 (Pubitemid 37329514)
70. Sadzuka Y, Tokutomi K, Iwasaki F et al (2006) The phototoxicity of photofrin was enhanced by PEGylated liposome in vitro. Cancer Lett 241:42-48
71. Bourré L, Thibaut S, Fimiani M et al (2003) In vivo photosensitizing efficiency of a diphenylchlorin sensitizer: interest of a DMPC liposome formulation. Pharm Res 47:253-261 (Pubitemid 36259928)
72. Kiesslich T, Berlanda J, Plaetzer K et al (2007) Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan® -and Foslip® - based photodynamic treatment in human biliary tract cancer cell lines. Photochem Photobiol Sci 6:619-627 (Pubitemid 46889468)
73. Molinari A, Colone M, Calcabrini A et al (2007) Cationic liposomes, loaded with m-THPC, in photodynamic therapy for malignant glioma. Toxicol in vitro 21:230-234 (Pubitemid 46205081)
74. Casas A, Perotti C, Saccoliti M et al (2002) ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumor organ cultures. Br J Cancer 86:837-842 (Pubitemid 34250830)
75. Curic ND, Grafe S, Albrecht V, Fahr A(2008) Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumors in mice: A pilot study. J Photochem Photobiol B 91:41-50 (Pubitemid 351494453)
76. Nekvasil M, Zadinova M, Tahotna L et al (2007) Optimum modality for photodynamic therapy of tumors: Gels containing liposomes with hydrophobic photosensitizers. Drug Dev Res 68:235-252 (Pubitemid 350223934)
77. van Nostrum CF (2004) Polymeric micelles to deliver photosensitizers for photodynamic therapy. Adv Drug Deliv Rev 56:9-16 (Pubitemid 38045421)
78. Rijcken CJF, Hofman JW, van Zeeland F et al (2007) Photosensitiser-loaded biodegradable polymeric micelles: Preparation, characterization and in vitro PDT efficacy. J Control Release 124:144-153 (Pubitemid 350101885)
79. Jang WD, Nakagishi Y, Nishiyama N et al (2006) Polyion complex micelles for photodynamic therapy: incorporation of dendritic photosensitizer excitable at long wavelength relevant to improved tissue-penetrating property. J Control Release 113:73-79 (Pubitemid 43818161)
80. Wolinsky JB, Grinstaff MW (2008) Therapeutic and diagnostic applications of dendrimers for cancer treatment. Adv Drug Deliv Rev 60:1037-1055
81. Sharman WE, van Lier JE, Allen CM (2004) Targeted photodynamic therapy via receptor mediated delivery systems. Adv Drug Deliv Rev 56:53-76 (Pubitemid 38045424)
82. Verma S, Watt GM, Mai Z, Hasan T (2007) Strategies for enhanced photodynamic therapy effects. Photochem Photobiol 83:996-1005 (Pubitemid 47438530)
83. Choi Y, McCarthy JR, Weissleder R, Tung C-H (2006) Conjugation of a photosensitizer to an Oligoarginine-based cellpenetrating peptide increases the efficacy of photodynamic therapy. Chem Med Chem 1:458-463
84. Frochot C, Di Stasio B, Vanderesse R et al (2007) Interest of RGD-containing linear or cyclic peptide tetraphenylchlorin as novel photosensitizers for selective photodynamic activity. Bioorg Chem 35:205-220 (Pubitemid 46671403)
85. Gilyanova DG, Rosenkranz AA, Gulak PV et al (2006) Targeting cancer cells by novel engineered modular transporters. Cancer Res 66:10534-10540 (Pubitemid 44799776)
86. Parveen S, Sahoo SK (2008) Polymeric nanoparticles for cancer therapy. J Drug Res 16:108-123 (Pubitemid 351266548)
87. Allison RR, Mota HC, Bagnato VS, Sibata CH (2008) Bio-nanotechnology and photodynamic therapy- State of the art review. Photodiagn Photodin Ther 5:19-28 (Pubitemid 351337662)
88. Lee H, Yu MK, Park S et al (2007) Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo. J Am Chem Soc 129:12739-12745 (Pubitemid 350004485)
89. Gu H, Xu K, Yang Z, Chang CK, Xu B (2005) Synthesis and cellular uptake of porphyrin decorated iron oxide nanoparticles-a potential candidate for bimodal anticancer therapy. Chem Commun 4270-4272 (Pubitemid 41345332)
90. Korbelik M (2006) PDT-associated host response and its role in the therapy outcome. Lasers Surg Med 38:500-508
91. Castano AP, Mroz P, Hamblin MR (2006) Photodynamic therapy and anti-tumor immunity. Nature Rev Cancer 6:535-545
92. Qiang Y-G, Yow CMN, Huang Z (2008) Combination of photodynamic therapy and immunomodulation: current status future trends. Med Res Rev 28:632-644 (Pubitemid 351842144)
93. Korbelik M, Sun J, Cecic I, Serrano K (2004) Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors. Photochem Photobiol Sci 3:812-816 (Pubitemid 39302983)
94. Ferrario A, Fisher AM, Rucker N, Gomer CJ (2005) Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res 65:9473-9479
95. Gomer JC, Ferrario A, Luna M, et al (2006) Photodynamic therapy: Combined modality approaches targeting the tumor microenvironment. Lasers Surg Med 38:516-521
96. Ferrario A, Gomer CJ (2006) Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model. J Environ Path Tox Oncol 25:251-259 (Pubitemid 43341245)
97. Ferrario A, Chantrain CF, vonTiehl F et al (2004) The matrix metalloproteinase inhibitor Prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model. Cancer Res 64:2328-2332 (Pubitemid 38523882)
98. Kosharsky B, Solban N, Chang SK et al (2006) A mechanismbased combination therapy reduces local tumor growth and metastasis in orthotopic model of prostate cancer. Cancer Res 66:10953-10958 (Pubitemid 44876994)
99. Sinha AK, Anand S, Ortel BJ et al (2006) Methotrexate used in combination with aminolevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer 95:485-495 (Pubitemid 44232558)
100. Yanase S, Nomura J, Matsumura Y et al (2006) Synergistic interaction of 5-aminolevulinic acid-based photodynamic therapy with simultaneous hyperthermia in an osteosarcoma tumor model. Int J Oncol 29:365-373
101. Kelleher DK, Bastian J, Thews O, Vaupel P (2003) Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumors. Br J Cancer 89:405-411 (Pubitemid 36976333)
102. Chen B, Roskams T, de Witte PAM (2002) Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia. Lasers Surg Med 31:158-163
103. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48-58 (Pubitemid 37328807)
104. Gillet JP, Efferth T, Remacle J (2008) Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochim Biophys Acta 1762:510-524
105. Robey RW, Steadman K, Polgar O, Bates SE (2005) ABCG2-Mediated transport of photosensitizers: Potential impact on photodynamic therapy. Cancer Biol Ther 4:187-194 (Pubitemid 41351317)
106. Liu W, Baer MR, Bowman MJ et al (2007) The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2. Clin Cancer Res 13:2463-2469